IRadimed Corporation

NASDAQ:IRMD

Medical - Devices

Healthcare
$82.31 +0.73%

+$0.67 today

Market cap
$1.05B
Beta
0.92
P/E (TTM)
49.7
EPS (TTM)
$1.85
Dividend yield
1.35%
52W Low $55.11High $107.90

Volume 0.08M

Average 0.12M

IRMD Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

IRadimed CorporationNASDAQ: IRMD

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit grows in line with its trailing trend

Q1 FY2026 gross profit of $16.81M rose 13.3% year over year, behind the +14.7% change in trailing-twelve-month gross profit. Sequentially, it fell 1.3% from the prior quarter. Over 3 fiscal years it compounded at +15.9% a year.

Context

  • Gross profit amounted to 76.7% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Gross profit increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +13.3% toward the trailing-twelve-month pace of +14.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$16.81M-1.3% QoQ
Last fiscal yearDec 2025
$64.32M+14.2% YoY
LTMMar 2026
$66.3M+14.7% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+13.3%——
1 year+14.2%——
3-year CAGR+15.9%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
64.32M USD
Year-over-year change
+14.2%
4-year CAGR
+19.0%

Gross Profit vs competitors

How IRMD compares with its peers on the latest reported figures

  • IRMD's LTM Mar 2026 gross profit of $66.3M is the lowest of the 11 companies compared; the peer median is $303.6M.
  • Its year-over-year change of +14.7% is the 4th highest of 11, against a peer median of +5.0%.
  • Gross profit amounts to 76.8% of revenue for IRMD, versus a peer median of 58.0%.
IRMD Competitors Peer median
Gross Profit for IRMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$875.04M +0.6%-4.5%53.2%
GDRXGoodRx Holdings, Inc.LTM Mar 2026$681.98M -8.9%+1.8%86.6%
CTEVClaritev CorporationLTM Mar 2026$597.67M -13.1%-32.7%61.1%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$564.4M +10.0%+8.7%54.9%
MDXGMiMedx Group, Inc.LTM Mar 2026$315.59M +9.4%+16.3%81.0%
INMDInMode Ltd.LTM Mar 2026$291.61M -7.1%-8.6%77.8%
AXGNAxoGen, Inc.LTM Sep 2026$198M +23.4%+15.4%74.2%
AHCOAdaptHealth Corp.LTM Apr 2026$153.98M +23.2%+10.8%5.4%
OPKOPKO Health, Inc.LTM Mar 2026$132.08M -33.7%-23.7%22.7%
CRONCronos Group Inc.LTM Mar 2026$67.49M +95.9%+58.7%32.8%
IRMDIRadimed CorporationLTM Mar 2026$66.3M +14.7%+15.9%76.8%
Peer median (excluding IRMD) $303.6M+5.0%+5.2%58.0%

Competitors are the stored peer set for IRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue41.81M53.3M65.56M73.24M83.81M
Cost of Revenue9.76M12.02M15.4M16.89M19.49M
Gross Profit32.05M41.28M50.16M56.35M64.32M
Gross Margin76.6%77.4%76.5%76.9%76.7%
Research & Development1.91M2.28M2.86M2.83M2.98M
Selling, General & Admin20.33M23.38M27.26M31.55M35.2M
Operating Expenses22.23M25.65M30.12M34.39M38.18M
Depreciation & Amortization1.41M670.67K765.18K817.66K2.38M
EBITDA11.24M16.85M22.5M25.09M30.74M
EBITDA Margin26.9%31.6%34.3%34.3%36.7%
Operating Income9.82M15.63M20.04M21.96M26.15M
Operating Margin23.5%29.3%30.6%30.0%31.2%
Interest Income34.81K581.85K1.86M2.19M0
Interest Expense00000
Other Income / Expenses18.61K553.1K1.7M2.31M2.21M
Income Before Tax9.84M16.18M21.74M24.28M28.36M
Pre-Tax Margin23.5%30.4%33.2%33.1%33.8%
Income Tax Expense510.82K3.35M4.55M5.04M5.88M
Net Income9.33M12.83M17.19M19.23M22.48M
Net Margin22.3%24.1%26.2%26.3%26.8%
EPS (Basic)0.761.021.361.521.77
EPS (Diluted)0.741.021.351.501.75
Weighted Avg Shares12.35M12.56M12.6M12.67M12.72M
Weighted Avg Shares (Diluted)12.59M12.64M12.72M12.78M12.85M

IRadimed Corporation

NASDAQ:IRMD

Intrinsic Alpha fair value

Locked

Current Price

$82.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.